Litcius/Paper detail

Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial

Michelle L M Mulder, Johanna E Vriezekolk, Tamara W van Hal, Lieke M Nieboer, Nathan den Broeder, E.M.G.J. de Jong, Alfons A den Broeder, F.H.J. van den Hoogen, Philip Helliwell, Mark H. Wenink

2022The Lancet Rheumatology24 citationsDOI

Topics & Concepts

MedicineLeflunomidePsoriatic arthritisMethotrexatePlaceboDactylitisInternal medicineCombination therapyPopulationArthritisSurgeryEnthesitisAlternative medicinePathologyEnvironmental healthSpondyloarthritis Studies and TreatmentsRheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research
Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial | Litcius